Target intelligence / Profile preview

Sarcin-ricin loop of the 28S ribosomal RNA (SRL) (SRL)

Target
SRL
Molecular classification
Ribosomal RNA, Ribonucleic acid, Ribosomal subunit component
01

Overview

The sarcin-ricin loop (SRL) is a highly conserved, 12-nucleotide sequence located within the 28S ribosomal RNA of the eukaryotic 60S ribosomal subunit (Garcia-Ortega et al., 2010). It serves as a critical functional center for protein synthesis, specifically facilitating the binding of translation elongation factors eEF1 and eEF2 and stimulating their essential GTPase activity (Shi et al., 2016). The SRL is the primary molecular target for Ribosome-Inactivating Proteins (RIPs), such as ricin, abrin, and Shiga toxin (Endo & Tsurugi, 1987). These toxins are often recruited to the SRL via interactions with the ribosomal P-stalk proteins (P0, P1, and P2), which guide the toxins to their site of action (Grela et al., 2019). Once at the SRL, RIPs typically function as N-glycosidases that depurinate a specific, universally conserved adenine residue, A4324 in humans (Endo & Tsurugi, 1987). This single modification irreversibly inactivates the ribosome by preventing elongation factor binding, leading to a rapid cessation of protein synthesis and subsequent cell death via apoptosis (Shi et al., 2016). In clinical research, this mechanism is exploited to develop immunotoxins, where RIPs are conjugated to antibodies to selectively eliminate malignant cells (Garcia-Ortega et al., 2010).

Other names
SRLAlpha-sarcin loop28S rRNA sarcin-ricin loopRicin/sarcin loopGTPase-associated center
02

Mechanism of action

Ribosome-inactivating proteins (RIPs) are recruited to the 60S subunit by the P-stalk proteins and subsequently depurinate the A4324 residue of the 28S rRNA sarcin-ricin loop, which sterically hinders the binding of elongation factors and halts translation.

03

Biological functions

Protein synthesisTranslation elongationGTPase activationRibosomal translocation
04

Disease associations

InfectionCancerToxicity
05

Safety considerations

Systemic toxicityVascular leak syndromeImmunogenicityOff-target cytotoxicityHepatotoxicity
06

Interacting drugs

Ricin

6 more in the full profile.

07

Biomarkers

Depurinated 28S rRNAInhibition of protein synthesisCaspase-3 activationApoptotic cell death

Beyond the preview

Go deeper on Sarcin-ricin loop of the 28S ribosomal RNA (SRL) (SRL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sarcin-ricin loop of the 28S ribosomal RNA (SRL) (SRL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call